Herbal Dispatch ($HERB / $LUFFF) is CRUSHING it on Cannabis Exports to Europe – The Bull Case is Exploding Right Now!
Fellow investors, if you’re sleeping on Herbal Dispatch’s international export machine, wake up! This Canadian craft leader is executing at warp speed across multiple regulated markets. From record-breaking flower shipments to Germany via Portugal to high-margin gummy exports to Australia, HD is building a diversified, high-growth global revenue stream. Premium Canadian cannabis is winning big time. Here’s the full export-focused breakdown.
Key Export Milestones & Timeline (All Markets – Pure Execution Mode)
- Ongoing 2025 Foundation: Strong baseline exports to Australia and Portugal, plus first order to Brazil. Export revenue already up massively YoY in prior years, setting the stage for 2026 acceleration.
- January 22, 2026: Inaugural 298kg medical cannabis flower export to Germany via EU-GMP licensed processor in Portugal. First major European entry – proof of concept secured.
- April 30, 2026: First international gummy export to Australia – $350,000 in revenue from a single shipment! Delivered premium medical cannabis gummies to a top 3 global cannabis company. Huge validation of edibles strategy and high-margin potential. Follow-on orders expected throughout 2026.
- May 14, 2026: Exclusive strategic supply agreement with the Portugal EU-GMP processor. Unlocks scalable processing, packaging, and distribution into Germany + other EU markets. Higher-value formats (vapes, concentrates, etc.) now in play.
- May 19, 2026 (TODAY): Company-record 500kg medical cannabis shipment to Europe – largest in HD history! More permits secured, pipeline full.
Rapid scaling in action: Flower to Europe ramping hard + edibles breaking into Australia = diversified momentum. Permitting timelines are shrinking fast (from weeks to days), enabling consistent quarterly volume growth.
Global Export Footprint – Active & Expanding
Herbal Dispatch has built relationships across Australia, Portugal, Germany, Brazil, Czech Republic, UK, Switzerland, Costa Rica – and more coming. Focus on GMP/EU-GMP compliance for premium positioning.
- Australia: Long-term partner with dried flower shipments + now the game-changing gummy order. High-margin edibles opening doors for recurring revenue.
- Europe (Germany focus): Leveraging Portugal as a compliant hub for the EU’s largest medical market. Germany’s imports exploding – perfect tailwind.
- Others: Brazil, Czech, UK, etc., provide diversification and future upside.
Why This is Explosive – Market Tailwinds Everywhere
- Germany/Europe: Record imports (140+ tonnes in first 9 months of 2025, Q3 up 176% YoY). Annual quota ~192.5 tonnes. Market projected to ~USD 835M by 2028 at 28.5% CAGR, with 600k+ patients. Canada is a top supplier.
- Australia: Strong medical demand + telemedicine growth. HD’s gummies hit the sweet spot for convenience and margins.
- Broader: Global medical cannabis boom. Canadian exporters gaining share in regulated markets.
Bullish Projections (Export Side Only)
- 2026: 100%+ YoY export revenue growth targeted. Multiple 500kg+ Europe shipments + Australia gummy follow-ons. Several tonnes potential through Portugal channel alone. Edibles adding high-margin layer.
- 2027-2028: Triple export volumes company-wide. 2-3 new markets per year. Europe as major pillar, processed products boosting margins, diversified footprint de-risking the business.
- Longer-term: Recurring revenue streams from key partners (Germany via Portugal, Australia gummies) + new deals = compounding growth engine.
This is execution, not speculation. From $350k gummy pop in Australia to record 500kg Europe flower – Herbal Dispatch is turning international exports into a core growth driver while maintaining craft quality.
Reddit, what’s your take? $HERB / $LUFFF – next global cannabis winner? Price targets? Drop your DD below! 🌍🌿📈
(Not financial advice – DYOR. All info from company releases and industry reports as of May 2026.)
